Elevate Your Psoriasis Care and Boost Your Expertise: Join the IPC Psoriasis Masterclass for North America in Chicago

IPC Psoriasis Masterclass North America Chicago, Illinois September 14-15, 2024

Are you an early-to-mid-career dermatologist, nurse practitioner, physician assistant, or dermatology resident dedicated to advancing your expertise in psoriasis care? If so, we have an exclusive opportunity tailored just for you!

IPC is pleased to announce the second annual IPC Psoriasis Masterclass for North America on September 14-15, 2024, in Chicago, Illinois. This educational program has already trained over 1,000 dermatologists and health care providers from more than 90 countries, and now it’s your turn to join this group of professionals.

”This was an amazing Masterclass! I learned many pearls, and I look forward to implementing them at my current practice.”

- 2023 IPC Psoriasis Masterclass for North America Attendee

Event Details:
Why Attend?

The IPC Psoriasis Masterclass for North America is more than just a training program; it’s a valuable experience designed to enhance your skills and knowledge in psoriasis care. Here’s why you should consider attending:

  • Comprehensive Curriculum: The Masterclass covers everything from the immunopathogenesis of psoriasis to the latest advancements in drug development and management of psoriasis-related comorbidities. You’ll also learn about optimizing topical, oral, and biologic therapies.
  • Expert Faculty: Led by international and regional experts, including IPC Vice President/President-Elect Bruce Strober, MD, PhD, and IPC Councilor Melinda Gooderham, MSc, MD, FRCPC, this program provides cutting-edge insights and practical knowledge.
  • Interactive Learning: Engage in dynamic lectures, panels, case-based discussions, and Q&A sessions designed to provide you with practical information and foster meaningful interactions.
  • Networking Opportunities: Connect with peers and join a global network of psoriasis advocates. This is your chance to build relationships that will support your professional growth.

”The small group/open discussion format is absolutely wonderful!”

- 2023 IPC Psoriasis Masterclass for North America Attendee

What’s Included?

Thanks to our generous sponsors, this program is entirely FREE. IPC will cover your 1-night stay at the Loews Chicago O’Hare Hotel and provide meals during the program, including an evening reception on Saturday and breakfast on Sunday.

NEW! Travel Scholarship: To support your attendance, we are excited to offer a $500 travel scholarship to the first 40 registrants. This scholarship can be used towards airfare and ground transportation expenses, making it easier for you to join us in Chicago for this exceptional educational opportunity.

Who Should Attend?

This program is perfect for early-to-mid-career health care professionals who are involved in psoriasis and psoriatic arthritis care, including:

  • Dermatologists
  • Nurse Practitioners
  • Physician Assistants
  • Dermatology Residents

”Perfect amount of time to learn without being oversaturated.”

- 2023 IPC Psoriasis Masterclass for North America Attendee

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and the International Psoriasis Council. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Claim only the credit commensurate with the extent of your participation.

How to Apply:

Ready to elevate your expertise in psoriasis care? Spaces are limited to 60 participants, so don’t delay! Submit your application before the registration deadline on Friday, July 12, 2024. Our team will review your submission and respond within one week to confirm your participation.

Secure your spot today and join us in Chicago for an enriching educational experience. Click here for more details and to apply.

We look forward to welcoming you to the IPC Psoriasis Masterclass for North America!

This Masterclass is supported in part by:

bristol myers squibb logo
Boehringer Logo
dermavant logo
Novartis Logo
[searchwp_search_form engine=blog_search target="/news" var=_blog_search]

Categories

Recent Posts

Six people stand side by side in business attire, smiling at the camera. Behind them, a banner reads IPC International Council 2025 Think Tank Puerto Rico, focused on Psoriasis in Latin America, with colorful designs and sunlight filtering through curtains.

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

A large group attends a conference session, with several panelists seated at a table onstage. One attendee stands to ask a question. The IPC (International Psoriasis Council) logo and AAD 2026 appear in the corner.

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

A man in a suit smiles at the camera next to text that reads, World Psoriasis Experts Give Their Take on Current, Hot, or Controversial Topics like Biologics in Psoriasis Management. EXPERT COMMENTARY.

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

Also Read

A man in a suit smiles at the camera next to text that reads, World Psoriasis Experts Give Their Take on Current, Hot, or Controversial Topics like Biologics in Psoriasis Management. EXPERT COMMENTARY.
biologics vs conventional therapy

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026